Trends in the share of high-cost drugs*

Share of total drug cost

(Please use a modern browser to see the interactive version of this visualization)

* Average annual drug costs per active beneficiary exceeding $10,000. Note: DAA=Direct-Acting Antiviral drugs

john sopinski / THE GLOBE AND MAIL Source: government of canada